Guardant Health Quote, Financials, Valuation and Earnings

Guardant Health Price Quote

-0.02 (-3.71%)
(Updated: April 20, 2024 at 6:17 AM ET)

Guardant Health Key Stats

Guardant Health (GH) is a Sell

Day range:
$15.81 - $16.79
52-week range:
$15.81 - $41.06
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Guardant Health Make?

Is Guardant Health Growing As A Company?

  • What Is Guardant Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.22%
  • What Is Guardant Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went down by -10.31% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price fell by -36.1% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

  • How Much Debt Does Guardant Health Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Guardant Health Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Guardant Health’s Book Value Per Share?
    Book value per share is 1.30

Is Guardant Health Cash Flow Positive?

  • What Is GH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$325M
  • What Is Guardant Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $477.4M
  • What Is Guardant Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $840.3M

Guardant Health Return On Invested Capital

  • Is Management Doing A Good Job?
    GH return on invested capital is -37.52%
  • What Is Guardant Health Return On Assets?
    ROA measures how assets are converting to revenues and is -28.05%
  • What Is GH Return On Equity?
    ROE is a measure of profitability and is -344.76%

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

Guardant Health Dividend Yield

Data Unavailable

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.24%
Revenue: 22.2% 2.83%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 40.13
Upside from Last Price: 149.38%

Major Shareholders

  • How many GH shares are owned by institutional investors?
    175.8M GH shares are owned by institutional investors
  • How many GH shares are owned by insiders?
    4.4M GH shares are owned by insiders